Peter Alan Karth, MD
NPI 1508181355ActiveIndividual· Ophthalmology, Retina Specialist· North Bend, OR
Ophthalmology, Retina Specialist (MD) in North Bend, Oregon, trained at University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) (class of 2009). In 2024 Medicare paid $3,554,108 for 489 patients, and Part D covered 169 of their prescriptions, 71% of them generic. Apellis Pharmaceuticals, Inc. was the largest of 7 companies reporting payments in 2025, $2,547 in all, mostly consulting fees.
Overview
| NPI | 1508181355 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | Yes |
| NPI issued | Apr 5, 2010 |
| Last updated in NPPES | Apr 21, 2026 |
| Certified by provider | Apr 21, 2026 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Ophthalmology, Retina Specialist Primary | 207WX0107X | MD175918 | OR |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Ophthalmology (LA); Practitioner - Ophthalmology (OR) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 489 |
|---|---|
| Services billed | 71,900 across 49 procedure codes |
| Paid by Medicare | $3,554,108 |
Part D prescriptions in 2024
| Prescriptions (claims) | 169 · 263 30-day fills |
|---|---|
| Patients | 83 |
| Total drug cost | $6,071 |
| Generic share | 71% of claims |
Education and affiliations
| Medical school | University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) |
|---|---|
| Graduation year | 2009 |
| Medicare specialty | Ophthalmology |
Industry payments (Open Payments)
- 2025$2,547 · 32 payments from 7 companies
- 2024$6,116 · 27 payments from 8 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Apellis Pharmaceuticals, Inc. | $1,602 | 3 |
| Genentech USA, Inc. | $353.21 | 6 |
| Astellas Pharma US Inc | $157.51 | 7 |
| Abbvie Inc. | $152.02 | 8 |
| Regeneron Healthcare Solutions, Inc. | $151.25 | 5 |
What the 2025 payments were for
- Consulting Fee$1,443 · 1 payment
- Food and Beverage$1,105 · 31 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records